These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 31272782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Minimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study.
    Cirillo E, Del Giudice E, Micheli R, Cappellari AM, Soresina A, Dellepiane RM, Pietrogrande MC, Dell'Era L, Specchia F, Pession A, Plebani A, Pignata C.
    Eur J Neurol; 2018 Jun; 25(6):833-840. PubMed ID: 29489040
    [Abstract] [Full Text] [Related]

  • 3. Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia.
    Buoni S, Zannolli R, Sorrentino L, Fois A.
    Arch Neurol; 2006 Oct; 63(10):1479-82. PubMed ID: 17030666
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients.
    Broccoletti T, Del Giudice E, Amorosi S, Russo I, Di Bonito M, Imperati F, Romano A, Pignata C.
    Eur J Neurol; 2008 Mar; 15(3):223-8. PubMed ID: 18290844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity.
    Russo I, Cosentino C, Del Giudice E, Broccoletti T, Amorosi S, Cirillo E, Aloj G, Fusco A, Costanzo V, Pignata C.
    Eur J Neurol; 2009 Jun; 16(6):755-9. PubMed ID: 19475758
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Steroid treatment in Ataxia-Telangiectasia induces alterations of functional magnetic resonance imaging during prono-supination task.
    Quarantelli M, Giardino G, Prinster A, Aloj G, Carotenuto B, Cirillo E, Marsili A, Salvatore E, Del Giudice E, Pignata C.
    Eur J Paediatr Neurol; 2013 Mar; 17(2):135-40. PubMed ID: 22763152
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial.
    Beyraghi-Tousi M, Sahebkar A, Houra M, Sarvghadi P, Jamialahmadi T, Bagheri R, Tavallaie S, Gumpricht E, Saberi-Karimian M.
    Eur J Paediatr Neurol; 2024 May; 50():57-63. PubMed ID: 38669738
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multi-drugs resistant acne rosacea in a child affected by Ataxia-Telangiectasia: successful treatment with Isotretinoin.
    Cantarutti N, Claps A, Angelino G, Chessa L, Callea F, El Hachem M, Diociaiuti A, Finocchi A.
    Ital J Pediatr; 2015 Mar 28; 41():23. PubMed ID: 25881033
    [Abstract] [Full Text] [Related]

  • 16. Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP.
    Hetland ML, Østergaard M, Ejbjerg B, Jacobsen S, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skjødt H, Ellingsen T, Lindegaard H, Pødenphant J, Hørslev-Petersen K, CIMESTRA study group.
    Ann Rheum Dis; 2012 Jun 28; 71(6):851-6. PubMed ID: 22302316
    [Abstract] [Full Text] [Related]

  • 17. [The intraarticular and local administration of glucocorticosteroid preparations].
    Siró B.
    Orv Hetil; 2009 Feb 08; 150(6):251-60. PubMed ID: 19179257
    [Abstract] [Full Text] [Related]

  • 18. A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype.
    Quek H, Luff J, Cheung K, Kozlov S, Gatei M, Lee CS, Bellingham MC, Noakes PG, Lim YC, Barnett NL, Dingwall S, Wolvetang E, Mashimo T, Roberts TL, Lavin MF.
    Hum Mol Genet; 2017 Jan 01; 26(1):109-123. PubMed ID: 28007901
    [Abstract] [Full Text] [Related]

  • 19. ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
    Menotta M, Biagiotti S, Spapperi C, Orazi S, Rossi L, Chessa L, Leuzzi V, D'Agnano D, Soresina A, Micheli R, Magnani M.
    Orphanet J Rare Dis; 2017 Jul 05; 12(1):126. PubMed ID: 28679388
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of fetal adrenal adrenocorticotropin receptor messenger ribonucleic acid expression by betamethasone administration to the baboon fetus in late gestation.
    Leavitt MG, Aberdeen GW, Burch MG, Albrecht ED, Pepe GJ.
    Endocrinology; 1997 Jul 05; 138(7):2705-12. PubMed ID: 9202207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.